Review of tests for monitoring doxorubicin-induced cardiomyopathy

Oncology
W I GanzA Serafini

Abstract

The objective of this review is to make physicians aware of new radionuclide methods to detect cardiac effects of chemotherapeutic drugs. This knowledge is important because of the limitations of the physical examination and the electrocardiogram for detecting early reversible cardiac damage. Presently left ventricular ejection fraction (LVEF) is routinely used to screen for cardiotoxicity. Since LVEF obtained by radionuclide angiocardiography is more accurate than the LVEF estimated by echocardiography, serial radionuclide LVEF monitoring is most commonly used to monitor cardiotoxicity. Diastolic measurements of left ventricular function (such as peak filling rate) are now being added to routine LVEF measurements to enhance standard radionuclide evaluation. This screening test should be done prior to beginning therapy and at appropriate points based on the baseline study, therapy scheme and the patient's clinical status. At some centers, exercise LVEF methods are being used to determine if cardiac reserve is adequate for the patient to tolerate additional chemotherapy when cardiac injury may be present. Previously, endomyocardial biopsy was needed to detect and confirm early anthracycline cardiotoxicity. This invasive test may...Continue Reading

Citations

Mar 3, 2012·Current Heart Failure Reports·Amir Y Shaikh, Jeffrey A Shih
Dec 23, 2011·Cardiovascular Toxicology·Ornella GarroneMauro Feola
Mar 7, 2013·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Kenneth J Nichols, Denny D Watson
Jun 21, 2005·The Journal of Laboratory and Clinical Medicine·Giorgina SpecchiaArcangelo Liso
May 15, 2002·The American Journal of Cardiology·Jörg M StrotmannWolfram Voelker
Feb 13, 2001·Clinica Chimica Acta; International Journal of Clinical Chemistry·S FredericksD W Holt
Apr 21, 1998·Critical Reviews in Oncology/hematology·A GiantrisS E Lipshultz
Sep 24, 1998·The New England Journal of Medicine·P K Singal, N Iliskovic
Oct 25, 2003·Journal of Cardiovascular Pharmacology·Matthias SpindlerRalf Gold
Feb 1, 2007·Nuclear Medicine Communications·Kenneth J Nichols, Diwakar Jain
Oct 24, 2009·Clinical Nuclear Medicine·Marta J AikenDouglas Van Nostrand
Mar 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven E LipshultzStephen E Sallan
Oct 28, 2003·Circulation Journal : Official Journal of the Japanese Circulation Society·Naoyuki YokoyamaTakaaki Isshiki
Jan 28, 2004·Circulation Journal : Official Journal of the Japanese Circulation Society·Eikan KohHiroaki Takahashi
Aug 3, 2006·American Journal of Veterinary Research·Rute Chamié Alves de Souza, Aparecido Antonio Camacho
Jan 1, 2009·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Navin KhattrySubhash Varma
Jan 25, 2014·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Jan M HoracekJaroslav Maly
Jul 27, 2014·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Kenneth J Nichols, Andrew Van Tosh
Jun 25, 2014·Canadian Journal of Physiology and Pharmacology·Mahwash F SaeedDavinder S Jassal
Oct 11, 2013·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Christopher M WalkerGautham P Reddy
Aug 19, 2009·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Ho Sup LeeYang Soo Kim
Nov 10, 2009·Canadian Journal of Physiology and Pharmacology·Ana R Lehenbauer LudkePawan K Singal
Apr 23, 2004·Leukemia & Lymphoma·András ZsáryIstván Karádi
Oct 19, 2006·Expert Opinion on Drug Safety·Robin L JonesMichael S Ewer
Oct 8, 2013·Journal of Drug Targeting·Baolong WangMeiqing Feng
Mar 20, 2003·Cancer Investigation·Sae HahmJacob J Steinberg
Apr 4, 2014·Scandinavian Journal of Clinical and Laboratory Investigation·Michela SalvaticiMaria T Sandri
Nov 8, 2015·Advanced Drug Delivery Reviews·Quanyin HuZhen Gu
May 2, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·V B Pai, M C Nahata
May 24, 2016·IJC Heart & Vasculature·Maria A Mitry, John G Edwards
Aug 21, 2012·Research in Veterinary Science·Fábio N GavaAparecido A Camacho
Jun 26, 2012·La Presse médicale·Marion CastelAtul Pathak
Aug 24, 2010·Progress in Cardiovascular Diseases·Quinn S Wells, Daniel J Lenihan
May 9, 2009·La Presse médicale·Gerald RoulAri Lieber
Mar 10, 2016·Journal of Cardiothoracic and Vascular Anesthesia·Adriana D OpreaMaysa Abu-Khalaf
Mar 3, 2007·Progress in Cardiovascular Diseases·Genzou Takemura, Hisayoshi Fujiwara
Mar 5, 2005·Pediatric Blood & Cancer·Randy W Braith
Oct 28, 2006·European Journal of Heart Failure·Mark BelhamColin Pritchard
Dec 25, 2010·Clinical Cardiology·Robert A HongRobert M Eager

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.